Recent News and Articles on the Keywords: drug + pharma + tranzyme  Related to the article below (Last Update: 12/9/2008)

US Chapter of 'Advinus Therapeutics' Inaugrated
MedIndia, India - Nov 12, 2008
Eric joins Advinus from Tranzyme Pharma where he was Vice President of Business Development and Licensing. Previously he was Assistant Vice President of ...

Pharma Times (registration)
India?s Advinus launches US subsidiary
Pharma Times (registration), UK - Nov 13, 2008
Nelson joins the Indian company from Tranzyme Pharma, where he was vice president of business development and licensing. He was previously assistant vice ...
Source: Google News

Tranzyme Pharma mulls cash options to test drug

Triangle Business Journal - by Frank Vinluan

  • Print
  • Email
  • Reprints
  • RSS Feeds
  • Add to Del.icio.us
  • Digg This
Dathan Kazsuk
Tranzyme CEO Vipin Garg says selling the company is possible.
View Larger

DURHAM – The shakedown of the financial markets has forced executives of a local pharmaceutical upstart to redraw their options.

With solid results from phase II clinical trials in hand, Tranzyme Pharma has three choices for its next move – finding a partner, raising as much as $60 million or selling the company to underwrite human tests.

Vipin Garg, the Durham company’s president and CEO, says phase III clinical trials on Tranzyme’s lead drug, a treatment to help restore the gastrointestinal tract to normal function following abdominal surgery, are scheduled to start early next year.

Garg says his company is talking with six large pharmaceutical companies based in the United States and abroad about a partnership or even a sale of the company that could take Tranzyme’s drugs all the way to commercialization.


This article is for Paid Print Subscribers ONLY.

If you are already a Triangle Business Journal subscriber please create or sign into your bizjournals.com account to link your valid print subscription and have access to the complete article.

Become a Print Subscriber

Triangle Business Journal For immediate access to this article, as well as the most recent edition of Triangle Business Journal online, become a print subscriber.
Subscribe now to Triangle Business Journal
Create a Bizjournals Account

Already have an Account

Forgot Your Password?

  • Print
  • Email

 

ICONOCAST DOES NOT HAVE ANY COPYRIGHTED MATERIAL OR WE WILL REMOVE IT. THE ARTICLES PRESENTED ARE PRESS RELEAES (NON-COPYRIGHTED) FROM MAJOR EDUCATIONAL & RESEARCH ESTABLISHMENTS THAT YOU CAN ALSO FIND ON WEBSITES SUCH AS MEDICALNEWSTODAY.COM